Cytoprotective agent
USRE47684E1 · kind E1 · reissue
3Cited by
1References
67Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 25, 2017 |
| Grant date | Nov 5, 2019 |
| Priority date | — |
| Expiry date | Apr 25, 2037 |
Classification
- Technology area (CPC —)General
Abstract
Disclosed is a cytoprotective agent for use with respect to ischemic damage, including as an active ingredient a triprenyl phenol compound represented by the following general formula (I), wherein X is —CHY—C(CH3)2Z, Y and Z are each independently —H or —OH, or jointly form a single bond, and R represents a hydrogen atom or a substituent with a molecular weight of 1000 or less.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.